Alex joined Sofinnova BioEquities in 2021 as an Analyst. He focuses on public investments in global biotech and pharmaceutical companies.
Prior to Sofinnova, Alex was a Senior Equity Research Associate at Raymond James focused on Biotech Equity Research. Before Raymond James, Alex was a Technology and Product Development Staff Engineer at BECTON, DICKINSON, & COMPANY covering BD Life Sciences. He began his career as a Bioengineering Scientist on the Canon Biomedical team at Canon USA Inc
Alex received his MS and PhD in Biomedical Engineering from the University of Wisconsin along with a B.S. in Applied Sciences from the University of North Carolina.